Nexalin Technology has a total of 11 patents globally, out of which 2 have been granted. Of these 11 patents all the patents are active. The United States of America is where Nexalin Technology has filed the maximum number of patents, followed by China and Hong Kong. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Nexalin Technology.
Nexalin Technology was founded in 2010. Nexalin Technology, Inc. operates as a medical device company. The Company designs and develops an easy-to-administer medical device that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Nexalin Technology serves customers worldwide.
Do read about some of the most popular patents of Nexalin Technology which have been covered by us in this article and also you can find Nexalin Technology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nexalin Technology patent portfolio.
How many patents does the Founder and CEO of Nexalin Technology have?
The Founder Randall Letcavage has 5 patents and the CEO Mark White has 0 patents.
How many patents does Nexalin Technology have?
Nexalin Technology has a total of 11 patents globally. These patents belong to 5 unique patent families. Out of 11 patents, all the patents are active.
How Many Patents did Nexalin Technology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Nexalin Technology Applications Filed||Nexalin Technology Patents Granted|
How many Nexalin Technology patents are Alive/Dead?
How Many Patents did Nexalin Technology File in Different Countries?
Countries in which Nexalin Technology Filed Patents
|United States Of America||5|
|Hong Kong (S.A.R.)||1|
Where are Research Centers of Nexalin Technology Patents Located?
The research center of all Nexalin Technologies patents is the United States of America.
Best Nexalin Technology Patents
US7769463B2 is the most popular patent in the Nexalin Technology portfolio. It has received 34 citations so far from companies like Neuroenabling Technologies, Elminda Ltd, and Nevro Corp.
What Percentage of Nexalin Technology US Patent Applications were Granted?
Nexalin Technology (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Nexalin Technology patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Nexalin Technology?
|Law Firm||Total Applications||Success Rate|
|Stetina Brunda Garred & Brucker||3||0%|
|Kalaco Scientific Inc||1||100.00%|
|Lewis Roca Rothgerber Christie Llp||1||100.00%|
List of Nexalin Technology Patents –
|US20220023616A1||Alternating Current Dynamic Frequency Stimulation System And Method For Opioid Use Disorder (Oud) And Substance Use Disorder (Sud)|
|US20220023615A1||Alternating Current Dynamic Frequency Stimulation System And Method For Anxiety, Depression, And Insomnia (Adi)|
|US20220023629A1||Transcranial Alternating Current Dynamic Frequency Stimulation (Tacs) System And Method For Alzheimers And Dementia|
|US7769463B2||Multi-Channel Electrostimulation Apparatus And Method|
|US6904322B2||Transcranial Electrostimulation Apparatus And Method|
|CN114258315A||Ac Dynamic Frequency Stimulation Systems And Methods For Anxiety, Depression And Insomnia (Adi)|
|CN113967317A||Transcranial Alternating Current Dynamic Frequency Stimulation (Tacs) System And Method For Alzheimers And Dementia|
|WO2022020045A1||Transcranial Alternating Current Dynamic Frequency Stimulation (Tacs) System And Method For Alzheimers And Dementia|
|WO2022020258A1||Alternating Current Dynamic Frequency Stimulation System And Method For Opioid Use Disorder (Oud) And Substance Use Disorder (Sud)|
|WO2022020156A1||Alternating Current Dynamic Frequency Stimulation System And Method For Anxiety, Depression, And Insomnia (Adi)|